Related Articles
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer
Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells
Androgen deprivation therapy has no effect on Pim-1 expression in a mouse model of prostate cancer
Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
Downregulation of lysine‑specific demethylase 1 enhances the sensitivity of hormone‑sensitive prostate cancer cells to androgen deprivation therapy